NASDAQ:KPTI - Karyopharm Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$9.33 +0.16 (+1.74 %)
(As of 02/20/2019 04:00 PM ET)
Previous Close$9.17
Today's Range$9.07 - $9.44
52-Week Range$8.01 - $21.71
Volume1.38 million shs
Average Volume865,436 shs
Market Capitalization$566.41 million
P/E Ratio-3.32
Dividend YieldN/A

Analyst Ratings

Karyopharm Therapeutics (NASDAQ:KPTI) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
11 Wall Street analysts have issued ratings and price targets for Karyopharm Therapeutics in the last 12 months. Their average twelve-month price target is $23.1111, suggesting that the stock has a possible upside of 147.71%. The high price target for KPTI is $30.00 and the low price target for KPTI is $18.00. There are currently 1 hold rating and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.912.913.002.89
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $23.1111$23.1111$23.1250$23.1250
Price Target Upside: 147.71% upside141.75% upside100.22% upside25.82% upside

Karyopharm Therapeutics (NASDAQ:KPTI) Consensus Price Target History

Price Target History for Karyopharm Therapeutics (NASDAQ:KPTI)

Karyopharm Therapeutics (NASDAQ:KPTI) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/3/2019Bank of AmericaUpgradeUnderperform ➝ NeutralHighView Rating Details
12/3/2018HC WainwrightReiterated RatingBuyHighView Rating Details
11/30/2018B. RileyInitiated CoverageBuy ➝ Buy$23.00LowView Rating Details
11/9/2018WedbushUpgradeNeutral ➝ Outperform$19.00LowView Rating Details
8/8/2018Robert W. BairdReiterated RatingBuy$25.00MediumView Rating Details
8/7/2018Canaccord GenuityReiterated RatingBuy$27.00MediumView Rating Details
5/1/2018Leerink SwannReiterated RatingOutperform$19.00 ➝ $24.00HighView Rating Details
4/30/2018Cantor FitzgeraldSet Price TargetBuy$18.00HighView Rating Details
4/25/2018Jefferies Financial GroupReiterated RatingBuyMediumView Rating Details
4/10/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$19.00 ➝ $20.00HighView Rating Details
3/2/2018Royal Bank of CanadaReiterated RatingBuy$22.00HighView Rating Details
(Data available from 2/20/2017 forward)
This page was last updated on 2/20/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel